Skip to main content

Table 3 Serology results for known infectious pathogens of myocarditis

From: Idiopathic acute myocarditis during treatment for controlled human malaria infection: a case report

Sera tested for antibodies to: Screening visit (paired with C + 17) C + 17 C + 17 (paired with C + 35) C + 35
Echovirus pool 20 < 10 (negative) < 10 (negative) 10
(Types 4, 6, 9, 14, 24, and 30)
Coxsackie virus pool 20 10 10 20
(Types A9, B1 – B6 )
Poliovirus 20 10 20 40
Adenovirus Ig 20 < 10 (negative) 20 20
Parvovirus IgM   negative   negative
Parvovirus IgG   64   64
Mycoplasma pneumoniae IgM negative negative   negative
Mycoplasma pneumoniae IgA negative negative   negative
Mycoplasma pneumoniae Ig < 10 (negative) < 10 (negative) < 10 (negative) < 10 (negative)
Chlamydia including Psittacosis Ig < 10 (negative) < 10 (negative) < 10 (negative) < 10 (negative)
Q fever phase 2 IgM negative negative   negative
Q fever Ig < 10 (negative) < 10 (negative) < 10 (negative) < 10 (negative)
Hepatitis B s-antigen   negative   negative
Hepatitis B anti-HBc   negative   negative
Hepatitis C Ig   negative   negative
Borrelia blot IgM   negative   negative
Borrelia blot IgG   negative   negative
Legionella serotype 1 – 7 IgM negative negative   negative
Legionella serotype 1 – 7 IgG negative negative   negative
Syphilis IgG   negative   negative
Toxoplasma IgG   negative   negative
  1. Serology results for known virological, bacteriological and parasitological causes of myocarditis based on samples taken at the screening visit, on day 17, and 35 after CHMI (C + 17 and C + 35, respectively). Paired serologic analysis was performed with serum drawn at the screening visit (three weeks before the start of the trial) for a number of pathogens. To detect potential delayed immune responses serologic analysis was repeated on day C + 35. Again, paired serologic analysis was performed with serum drawn on day C + 17 for a number of pathogens.